日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

SMARCA4 缺失导致卵巢小细胞癌(高钙血症型)中内含子滞留和肿瘤相关抗原的产生

Elizabeth A Raupach ,Apurva M Hegde ,Krystine Garcia-Mansfield ,Marice Alcantara ,David L Rose ,Rebecca F Halperin ,Krystal A Orlando ,Jessica D Lang ,Ritin Sharma ,Victoria David-Dirgo ,Salvatore J Facista ,Rayvon Moore ,Rochelle Kofman ,Zoe N Jensen ,Victoria L Zismann ,Anthony N Karnezis ,Yemin Wang ,Lynda B Bennett ,Timothy G Whitsett ,Marcin Kortylewski ,William P D Hendricks ,David G Huntsman ,Lorna Rodriguez-Rodriguez ,Bernard E Weissman ,Jeffrey M Trent ,Patrick Pirrotte

A Critical Role of Intracellular PD-L1 in Promoting Ovarian Cancer Progression

细胞内 PD-L1 在促进卵巢癌进展中发挥关键作用

Rui Huang, Brad Nakamura, Rosemary Senguttuvan, Yi-Jia Li, Antons Martincuks, Rania Bakkar, Mihae Song, David K Ann, Lorna Rodriguez-Rodriguez, Hua Yu

Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer

靶向 PARG 通过降低卵巢癌中的磷酸化 STAT3 来诱导肿瘤细胞生长抑制和抗肿瘤免疫反应

Antons Martincuks, Chunyan Zhang, Theresa Austria, Yi-Jia Li, Rui Huang, Nicole Lugo Santiago, Adrian Kohut, Qianqian Zhao, Rosemarie Martinez Borrero, Binghui Shen, Mihaela Cristea, Edward W Wang, Mihae Song, Lorna Rodriguez-Rodriguez, Hua Yu

Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting

CAR-T细胞中抗原依赖性IL-12信号传导促进从局部到全身性疾病靶向治疗

Eric Hee Jun Lee # ,John P Murad # ,Lea Christian ,Jackson Gibson ,Yukiko Yamaguchi ,Cody Cullen ,Diana Gumber ,Anthony K Park ,Cari Young ,Isabel Monroy ,Jason Yang ,Lawrence A Stern ,Lauren N Adkins ,Gaurav Dhapola ,Brenna Gittins ,Wen-Chung Chang ,Catalina Martinez ,Yanghee Woo ,Mihaela Cristea ,Lorna Rodriguez-Rodriguez ,Jun Ishihara ,John K Lee ,Stephen J Forman ,Leo D Wang ,Saul J Priceman

Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer

每日皮下注射 SPL-108 联合紫杉醇治疗铂类耐药 CD44+ 晚期卵巢上皮癌患者的 I 期临床试验

Eugenia Girda, June Hou, David Nelson, Malcolm Finlayson, Alexandre Buckley de Meritens, Marina Chekmareiva, Aliza Leiser, Mihae Song, Ruth Stephenson, Nancy Chan, Ana I Tergas, Reena Vattakalam, Jason D Wright, Hua Yu, Antons Martincuks, Adrian Kohut, Joycelynne Palmer, Lorna Rodriguez-Rodriguez

Niraparib-induced STAT3 inhibition increases its antitumor effects

尼拉帕尼诱导的 STAT3 抑制可增强其抗肿瘤作用

Qianqian Zhao, Adrian Kohut, Yi-Jia Li, Antons Martincuks, Theresa Austria, Chunyan Zhang, Nicole Lugo Santiago, Rosemarie Martinez Borrero, Xuan Thuy Phan, Laleh Melstrom, Lorna Rodriguez-Rodriguez, Hua Yu

PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian Cancer

PARP抑制激活肿瘤细胞和免疫细胞中的STAT3,从而导致卵巢癌的治疗耐药性和免疫抑制。

Antons Martincuks ,Jieun Song ,Adrian Kohut ,Chunyan Zhang ,Yi-Jia Li ,Qianqian Zhao ,Edward Mak ,Lorna Rodriguez-Rodriguez ,Hua Yu ,Mihaela Cristea

Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment

通过开发条件性复制腺病毒来靶向 CA-125 转录以治疗卵巢癌

Er Yue, Guangchao Yang, Yuanfei Yao, Guangyu Wang, Atish Mohanty, Fang Fan, Ling Zhao, Yanqiao Zhang, Tamara Mirzapoiazova, Tonya C Walser, Lorna Rodriguez-Rodriguez, Yuman Fong, Ravi Salgia, Edward Wenge Wang

RET rearrangements are actionable alterations in breast cancer

RET 重排是乳腺癌中可操作的改变

Bhavna S Paratala, Jon H Chung, Casey B Williams, Bahar Yilmazel, Whitney Petrosky, Kirstin Williams, Alexa B Schrock, Laurie M Gay, Ellen Lee, Sonia C Dolfi, Kien Pham, Stephanie Lin, Ming Yao, Atul Kulkarni, Frances DiClemente, Chen Liu, Lorna Rodriguez-Rodriguez, Shridar Ganesan, Jeffrey S Ross, 

Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy

用于磁共振成像和治疗的肿瘤靶向响应纳米粒子系统

Ronak Savla, Olga B Garbuzenko, Suzie Chen, Lorna Rodriguez-Rodriguez, Tamara Minko